Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT)
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 106 participants.
Also called NCT07920055
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 106 participants
- Sponsor
- Registry
-
NCT07920055
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07920055. Randomized; no masking; primary purpose treatment. Start 2026-11-01 (anticipated); primary completion 2028-08-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT)
- Acronym
- SPRIT
- Condition
- Coronary In-stent Restenosis
- Condition
- Coronary Artery Disease
- Intervention (Device)
- SeQuent SCB sirolimus-coated balloon
- Intervention (Drug)
- RESTORE DEB paclitaxel-coated balloon
- Lead sponsor
- Sir Run Run Shaw Hospital
Record details
- Record id
cardio:ct-nct07920055- Content hash
a6569ef90ce180e487f8fc2072c45eeed33266a15c2d67377db51d8edbdc43f0